HBM HEALTHCARE INVESTMENTS AG

(HBMN)
  Report
Delayed Swiss Exchange  -  05/18 10:06:12 am EDT
256.50 CHF   +0.98%
05/16Key Figures 15.05.2022
EQ
05/10Pfizer to acquire HBM portfolio company Biohaven Pharmaceuticals in USD 11.6 billion deal
EQ
05/06HBM Healthcare Investments Sinks To FY22 Loss On Negative Result From Investment Activities
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Key Figures 15.11.2021

11/16/2021 | 11:48am EDT

EQS Group-News: HBM Healthcare Investments AG / Key word(s): Monthly Figures
Key Figures 15.11.2021

16.11.2021 / 17:46


 

in CHF

Performance in %

 

15.11.2021

MTD

FYTD

CYTD

NAV

317.66

-2.7

6.8

12.6

Share Price

359.50

3.3

11.9

22.0

Total Net Assets (in million)

2'210.00

 

 

 

HBM Healthcare Investments AG
Bundesplatz 1
CH-6300 Zug - Switzerland
Tel.  +41 41 710 75 77
Fax  +41 41 710 75 78
 
Wenn Sie keine Mitteilungen von HBM Healthcare Investments mehr wünschen, können Sie diese hier abbestellen
Should you wish to unsubscribe from all HBM Healthcare Investments news, please unsubscribe here.
 
Disclaimer:

This message may contain confidential or privileged Information and is intended only for the use of the addressee named above. If you are not the intended recipient of this message, you are hereby notified that you must not use, copy, disclose or take any action based on this message or information herein. If you have received this message by error, please advise the sender immediately and delete this message. The publication is for information purposes only and does not constitute an offer to sell or a solicitation to buy or subscribe for securities. Past performance is not a reliable indicator or guarantee of future results, prices of shares and the income from them may fall as well as rise and investors may not get back the amount originally invested. The investor must be aware of the investment risk and personal risk ability. Some information quoted was obtained from external sources HBM considers to be reliable. HBM cannot guarantee the adequacy, accuracy, timeliness or completeness of or be held responsible or liable for errors of fact regarding such data and information obtained from third parties, and this data may change with market conditions.

If the email looks unformatted, please use this alternative link.


End of Media Release


Language: English
Company: HBM Healthcare Investments AG
Bundesplatz 1
6300 Zug
Switzerland
Phone: +41438887171
Fax: +41438887172
E-mail: info@hbmhealthcare.com
Internet: https://www.hbmhealthcare.com
ISIN: CH0012627250
Valor: 1262725
Listed: SIX Swiss Exchange
EQS News ID: 1249559

 
End of News EQS Group News Service

1249559  16.11.2021 

fncls.ssp?fn=show_t_gif&application_id=1249559&application_name=news&site_id=zonebourse_sftp

© EQS 2021
All news about HBM HEALTHCARE INVESTMENTS AG
05/16Key Figures 15.05.2022
EQ
05/10Pfizer to acquire HBM portfolio company Biohaven Pharmaceuticals in USD 11.6 billion de..
EQ
05/06HBM Healthcare Investments Sinks To FY22 Loss On Negative Result From Investment Activi..
MT
05/06HBM Healthcare Investments year-end results 2021/2022
EQ
05/02HBM Healthcare Investments Sees 3% Drop in April NAV
MT
05/02HBM HEALTHCARE INVESTMENTS : Key Figures 30.04.2022
PU
05/02Key Figures 30.04.2022
EQ
04/19HBM HEALTHCARE INVESTMENTS : Key Figures 15.04.2022
PU
04/19Key Figures 15.04.2022
EQ
04/03HBM Healthcare Investments' NAV Slips 4% In FY22
MT
More news
Analyst Recommendations on HBM HEALTHCARE INVESTMENTS AG
More recommendations
Financials
Sales 2022 267 M 269 M 269 M
Net income 2022 214 M 216 M 216 M
Net cash 2022 158 M 159 M 159 M
P/E ratio 2022 8,25x
Yield 2022 4,92%
Capitalization 1 767 M 1 780 M 1 780 M
EV / Sales 2022 6,03x
EV / Sales 2023 3,87x
Nbr of Employees 700
Free-Float 83,8%
Chart HBM HEALTHCARE INVESTMENTS AG
Duration : Period :
HBM Healthcare Investments AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HBM HEALTHCARE INVESTMENTS AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 254,00 CHF
Average target price 370,00 CHF
Spread / Average Target 45,7%
EPS Revisions
Managers and Directors
Andreas Wicki Chief Executive Officer
Erwin Troxler Chief Financial Officer
Hans-Peter Hasler Chairman
Rudolf Lanz Director
Mario Germano Giuliani Director
Sector and Competitors
1st jan.Capi. (M$)
HBM HEALTHCARE INVESTMENTS AG-25.07%1 780
BLACKROCK, INC.-33.19%92 678
BROOKFIELD ASSET MANAGEMENT INC.-17.92%76 430
BLACKSTONE INC.-16.74%75 489
UBS GROUP AG6.09%58 771
BANK OF NEW YORK MELLON CORPORATION (THE)-23.23%36 020